although
term
glyco
code
recent
come
use
recognit
carbohydr
signatur
microb
document
nearli
centuri
ago
dochez
averi
found
pneumococci
grown
fluid
media
substanc
cultur
fluid
precipit
specif
antisera
pneumococcu
heidelberg
averi
show
substanc
recogn
antibodi
carbohydr
molecul
protein
previous
thought
later
found
almost
everi
microorgan
express
glyco
code
recogn
host
immun
system
effect
stimul
specif
antibodi
respons
immunogen
carbohydr
moieti
often
serv
key
target
develop
vaccin
infecti
diseas
tumor
glycom
research
recent
year
uncov
larg
panel
tumorassoci
carbohydr
antigen
evid
immun
recognit
tumorderiv
aberr
carbohydr
carbohydr
capabl
gener
structur
divers
multipl
way
promin
display
surfac
cell
membran
expos
region
macromolecul
unlik
protein
connect
sole
peptid
bond
carbohydr
util
mani
possibl
glycosid
linkag
extens
diversifi
structur
two
amino
acid
residu
two
alanin
produc
one
possibl
dipeptid
howev
two
molecul
glucos
potenti
gener
differ
disaccharid
trimer
nine
common
sugar
residu
human
bodi
theoret
give
rise
differ
structur
isom
strike
contrast
maxim
construct
tripeptid
use
differ
amino
acid
residu
theoret
sugar
chain
structur
unlimit
variat
importantli
multipl
carbohydraterecognit
system
live
speci
read
biolog
inform
complex
carbohydr
two
exampl
numer
antiglycan
antibodi
produc
mani
anim
speci
play
key
role
protect
host
microbi
infect
famili
lectinlik
glycanbind
protein
gbp
evolv
carbohydratemedi
cellcel
commun
thu
carbohydr
uniqu
suitabl
store
biolog
signal
form
identifi
biolog
system
immunolog
glycobiolog
literatur
glycoepitop
often
use
specifi
carbohydr
moieti
recogn
antibodi
gbp
antibodybind
glycoepitop
also
classifi
b
cell
epitop
antigen
determin
conceptu
glycoepitom
refer
entir
repertoir
glycoepitop
includ
b
cell
epitop
recogn
gbp
differ
glycom
cover
exist
carbohydr
molecul
live
organ
glycoepitom
refer
uniqu
subset
carbohydr
serv
sugar
signatur
molecular
recognit
biosign
transmiss
glycoepitom
thu
evolv
area
glycom
research
focus
identifi
character
understand
carbohydr
moieti
serv
multipl
level
biocommun
structur
aspect
glycoepitom
focu
elucid
glycan
structur
display
glycoepitop
research
area
substanti
enhanc
develop
advanc
profil
structur
character
strategi
notabl
includ
highresolut
chromatographi
method
coupl
exoglycosidas
digest
modern
mass
spectrometri
nuclear
magnet
reson
spectroscopi
analys
carbohydr
stateofart
method
glycan
structur
model
howev
avail
carbohydr
structur
inform
alon
suffici
defin
glycoepitop
unless
specif
bind
antibodi
gbp
also
demonstr
immunochem
andor
crystallograph
exampl
chemic
determin
tetrasaccharid
decor
spore
bacillu
anthraci
appear
import
discoveri
microbi
glycom
base
past
knowledg
immunogen
carbohydr
moieti
structur
glycom
progress
may
suggest
uniqu
sugar
moieti
may
potenti
immunolog
applic
howev
whether
carbohydr
moieti
preserv
b
cell
epitop
potent
antigen
determin
must
determin
immunolog
includ
least
demonstr
antibodi
bind
specif
capac
elicit
immun
respons
vivo
integr
structur
immunolog
investig
support
carbohydr
microarray
technolog
reveal
anthrosetetrasaccharid
key
immunolog
target
b
anthraci
applic
may
includ
identif
presenc
b
anthraci
spore
surveil
diagnosi
anthrax
infect
develop
novel
vaccin
target
b
anthraci
spore
modern
carbohydr
microarray
emerg
introduc
new
glycom
tool
deciph
biolog
inform
content
glycom
technolog
especi
use
explor
repertoir
glycoepitom
given
structur
characterist
carbohydr
display
chip
carbohydr
microarray
classifi
monosaccharid
chip
oligosaccharid
chip
microarray
carbohydratecontain
macromolecul
latter
includ
polysaccharid
variou
glycoconjug
differ
sugar
chip
array
develop
accommod
multipurpos
applic
carbohydr
research
exampl
monoand
disaccharid
microarray
suitabl
screen
character
carbohydratebind
protein
carbohydratecatalyz
enzym
identifi
inhibitor
carbohydrateprotein
interact
howev
lectin
mani
antiglycan
antibodi
recogn
larger
complex
carbohydr
ligand
antigen
determin
monoand
disaccharid
sugar
chip
suffici
investig
involv
molecular
target
oligosaccharid
polysaccharid
glycoconjug
microarray
come
fill
gap
display
carbohydr
complex
structur
longer
sugar
chain
chip
one
import
research
area
glycoepitom
understand
natur
characterist
immunogen
sugar
moieti
render
key
target
immunolog
clinic
applic
figur
illustr
exampl
common
sugar
residu
glucos
form
either
nonimmunogen
highli
immunogen
polysaccharid
molecul
link
glucosyl
polym
illustr
digest
nonimmunogen
glycogen
microbeproduc
dextran
molecul
howev
immunogen
human
mani
anim
speci
owe
fact
dextran
glycogen
resist
host
enzymat
digest
persist
vivo
stimul
b
cell
respons
thu
whether
carbohydr
molecul
immunogen
determin
complex
process
antigen
process
host
recognit
regul
immun
respons
target
molecul
carbohydr
antigen
dextran
figur
upper
panel
may
display
differ
type
epitop
termin
intern
chain
glycoepitop
solventaccess
surfac
attribut
hydrophil
properti
carbohydr
make
strikingli
differ
protein
aqueou
solut
protein
tend
fold
bring
hydrophob
side
chain
togeth
form
oili
core
polar
side
chain
expos
surfac
moieti
protein
antigen
may
serv
antigen
determin
interact
bcell
igreceptor
interior
residu
gener
access
interact
carbohydr
built
monosaccharid
wherebi
enrich
hydroxi
group
readili
interact
water
molecul
hydrogen
bond
glycosid
linkag
flexibl
peptid
bond
protein
proteinlik
fold
pattern
seen
polysaccharid
thu
termin
carbohydr
chain
access
molecular
recognit
residu
intern
chain
also
expos
solvent
frequent
reactiv
mani
carbohydratebas
vaccin
focu
termin
nonreduc
end
epitop
leav
larg
class
intern
chain
epitop
unexplor
identifi
immunogen
carbohydr
moieti
perhap
one
current
challeng
carbohydr
research
sinc
earli
acquir
immunodefici
syndrom
aid
etiolog
agent
human
immunodefici
viru
hiv
first
describ
immunolog
complex
infecti
diseas
recogn
exampl
discoveri
oligomannos
cluster
epitop
broadli
antibodi
stimul
substanti
interest
carbohydr
moieti
develop
vaccin
howev
induct
neutral
antibodi
activ
immun
proven
difficult
exampl
ni
et
al
immun
rabbit
use
synthet
oligomannos
cluster
express
glycoepitop
found
antigen
elicit
small
fraction
antibodi
carbohydr
moieti
major
iggtyp
antibodi
direct
linker
conjug
rabbit
antisera
show
weak
crossreact
howev
demonstr
poorli
immunogen
antigen
necessarili
lead
conclus
oligomannos
antigen
gener
nonimmunogen
vivo
fact
sugar
chain
may
gener
differ
glycoepitop
sugar
moieti
present
differ
cluster
configur
essenc
sugar
chain
assembl
differ
antigen
carbohydr
antigen
may
interact
immun
system
differ
way
figur
illustr
three
exampl
glycoepitom
divers
nklh
similar
nbsa
linkag
use
coupl
oligomannos
protein
carrier
molar
ratio
unit
correspond
carrier
contrast
nklh
construct
introduc
defin
scaffold
display
tetraval
oligomannos
cluster
latter
mimic
highdens
express
glycoprotein
bind
select
neutral
monoclon
antibodi
mab
figur
blue
column
howev
tumor
vaccineelicit
mab
highli
reactiv
three
cluster
figur
red
column
thu
glycoconjug
express
epitop
common
differ
express
epitop
interestingli
reactiv
oligomannos
antigen
appear
immunogen
human
mous
certain
condit
evidenc
fact
autoantibodi
target
oligomannos
antigen
found
significantli
elev
blood
circul
men
aggress
prostat
cancer
cerebrospin
fluid
patient
multipl
sclerosi
serum
mice
experiment
autoimmun
encephalomyel
eae
interestingli
wang
et
al
found
coimmun
sjlj
mice
conjug
time
eae
induct
elicit
signific
level
autoantibodi
igg
igm
nevertheless
antiglycan
autoantibodi
respons
associ
significantli
reduc
clinic
sever
eae
thu
much
remain
learn
regard
molecular
cellular
mechan
underli
noteworthi
glyco
code
molecular
target
glycoepitom
studi
limit
glycoepitop
defin
antiglycan
antibodi
gbp
conceptu
carbohydr
moieti
play
role
molecular
recognit
biocommun
belong
famili
biocommun
may
includ
certainli
limit
carbohydr
serv
host
receptor
microorgan
specif
recogn
toxin
variou
origin
glycoepitop
divers
therefor
evolv
area
glycom
research
biomark
discoveri
